Psychopharmacology for the clinician

Journal of Psychiatry and Neuroscience

Volumn 36, Issue 4, 2011, Pages 35-36

  Boyd, Kerry ^a   Woodbury Smith, Marc ^a   Szatmari, Peter ^a  

^a MCMASTER UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

SEROTONIN UPTAKE INHIBITOR;

ADULT; AGITATION; AKATHISIA; ANXIETY; ARTICLE; AUTISM; CASE REPORT; CLINICAL FEATURE; CLINICAL PRACTICE; COMORBIDITY; DEPRESSION; HUMAN; MALE; MENTAL HEALTH; PATIENT MONITORING; PSYCHOPHARMACOLOGY; SIDE EFFECT; SLEEP DISORDER; SPEECH DISORDER; TREATMENT DURATION; CHILD;

ANXIETY; CHILD; CHILD DEVELOPMENT DISORDERS, PERVASIVE; DEPRESSION; HUMANS; MALE; SEROTONIN UPTAKE INHIBITORS; YOUNG ADULT;

EID: 79959681452     PISSN: 11804882     EISSN: 14882434     Source Type: Journal    
DOI: 10.1503/jpn.110040     Document Type: Article

References (6)

1. Williams K, Wheeler DM, Silove N, et al. Selective serotonin reuptake inhibitors (SSRIs) for autism spectrum disorders (ASD). Cochrane Databas Syst Rev 2010;(8):CD004677.
2. Kolevzon A, Mathewson K, Hollander E. Selective serotonin reuptake in hibitors in autism: a review of efficacy and tolerability. J Clin Psychiatry 2006; 67: 407-414.
3. McCracken JT. Safety issues with drug therapies for autism spectrum disorders. J Clin Psychiatry 2005;66; Suppl 10: 32-37.
4. King BH, Bostic JQ. An update on pharmacological treatments for autism spectrum disorders. Child Adolesc Psychiatr Clin N Am 2006;15:161-175.
5. Rosenberg RE, Mandell D, Farmer J, et al. Psychotropic medication use among children with autism spectrum disorders enrolled in a national registry, 2007-2008. J Autism Dev Disord 2010; 40: 342-351.
6. Deb S, Salvador-Carulla L, Barnhill J, et al., editors. Problem behaviours in adults with intellectual disabilities. international guide for using medication. Section on psychiatry of intellectual disability. Switzerland: World Psychiatric Association; 2008.